ESC 365 - Effect on Maximal Functional Capacity of Betablockers Withdrawal in Heart Failure with Preserved Ejection Fraction and Chronotropic Incompetence: Preserve-HR trial

HFA Premium Access

Effect on Maximal Functional Capacity of Betablockers Withdrawal in Heart Failure with Preserved Ejection Fraction and Chronotropic Incompetence: Preserve-HR trial

Session: Late-Breaking Trials 3

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor J. Nunez Villota (Valencia, ES)

Event: Heart Failure 2021

Congress Presentation

About the speaker

Doctor Julio Nunez Villota

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

11 presentations

1 follower

2 more presentations in this session

Effect of Dapagliflozin vs Placebo on Symptoms and Six-Minute Walk Distance in Patients with Heart Failure

Speaker: Professor J. McMurray (Glasgow, GB)

BAROSTIM therapy in patients with HFrEF: A patient level meta-analysis of randomized trials

Speaker: Professor A. Stewart Coats (Sydney, AU)

Access the full session

Late-Breaking Trials 3

Speakers: Doctor J. Nunez Villota, Professor J. McMurray, Professor A. Stewart Coats

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by